Evaluation of personal intervention compared to automated intervention and the effect on patient appointment adherence

Decreased patient appointment adherence affects a variety of health care delivery organizations nationwide impacting continuity of care, health outcomes, and healthcare costs. Poor appointment adherence increases financial burden resulting in delayed or missed care and poor utilization of clinic resources. Increased no-show rates in the primary clinics contribute to poor health outcomes, increased burden to staff, and decreased revenue

1336-P: Health-Care Utilization in T2D Youth in the Pediatric Diabetes Consortium (PDC)

Background: Youth with T2D experience barriers to obtaining diabetes care. We evaluated whether healthcare utilization (HCU) was associated with glycemic outcomes in youth with T2D. Methods: We evaluated annual HCU in 1,324 T2D PDC youth by diabetes duration up to 13 years post diagnosis. Medical record and self-reported HCU data were collected at enrollment and annually. Frequency of diabetes related inpatient admissions, Emergency Department (ED), urgent care, Diabetes Management (DM), Registered Dietician (RD) visits, and 911 calls were collected. Results: After adjusting for age, gender, diabetes duration, and annual visits, those with ≥1 admission/year, regardless of admission reason, (16%) had a higher A1c vs. those without admission, 8.8 vs. 8.4% (p=0.002). Those with ≥2 DM office visits/year (75%) had lower A1c vs. those with 0-1 visits, 8.4 vs. 8.8% (p=0.001). BMI and A1c did not differ by number of RD visits (p=0.63 and 0.39 respectively); RD visits/year decreased over time. Conclusions: In T2D youth, hospitalizations and &amp;lt;2 DM office visits/year are associated with higher A1c. Frequencies of ED and inpatient admissions for T2D are stable following the first year of T2D diagnosis. Only 24-38% of T2D youth had 4 DM visits/year while ∼50% have ≥3 visits a year, even with long T2D duration. Methods to improve follow-up care are needed to improve outcomes in youth with T2D. Disclosure G.J. Klingensmith: Consultant; Self; AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Takeda Pharmaceutical Company Limited. Research Support; Self; Novo Nordisk Foundation. Stock/Shareholder; Spouse/Partner; Dexcom, Inc. P. Cheng: None. R.L. Gal: None. L.C. Beaulieu: None. C. Kollman: None. R.L. Adams: None. T.S. Hannon: Advisory Panel; Self; Eli Lilly and Company. L.M. Looper: None. W.V. Tamborlane: Consultant; Self; AstraZeneca, Boehringer Ingelheim International GmbH, Eli Lilly and Company, Medtronic MiniMed, Inc., Novo Nordisk Inc., Sanofi, Takeda Pharmaceutical Company Limited. Funding Boehringer Ingelheim; Novo Nordisk; Takeda Pharmaceutical Company Limited </jats:sec

Notional Geological Traverses, Station Activities, and Sample Collection on Mons Malapert, Lunar South Polar Region

The geology of a potential Artemis landing site on Mons Malapert is examined using remote sensing techniques and lessons learned from Apollo missions to the lunar surface. Orthomosaics, digital terrain models, illumination models, thermal conditions, crater size-frequency distribution analyses, geomorphological mapping, spectral and compositional analyses, lunar surface physical property analyses, and image processing to reveal the lunar surface within permanently shadowed regions (PSRs) were integrated with anticipated crew capabilities to develop three notional extravehicular activity (EVA) traverses lasting 3, 3, and 6 hr each. The traverse plans recover 43 samples, with a mass of 44 kg, secured in 54 kg of sample containers, including those NASA requires for samples collected in and around PSRs, which is within the 100 kg limit NASA allows for a landed mission. The geologic plan for the EVAs addresses seven Artemis III science objectives, 25 science goals within those objectives, and 90 specific investigations of varying priority in the Artemis III Science Definition Team Report (43 high-, 40 medium-, 2 medium-high-, and 5 low-priority investigations); for example, test and reveal new details about the lunar magma ocean hypothesis, the basin-forming epoch and implications for Solar System architecture, sources and distribution of volatiles, and regolith physical properties relevant to human and robotic exploration.<br/